Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.
about
Pharmacological treatment options for mast cell activation diseaseFunctional deregulation of KIT: link to mast cell proliferative diseases and other neoplasmsMast cell activation syndrome: Proposed diagnostic criteria.Mast cell activation syndrome as a significant comorbidity in sickle cell disease.Familial occurrence of systemic mast cell activation disease.Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress.Mast Cell-Mediated Mechanisms of Nociception.Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells.Utility of hydroxyurea in mast cell activation syndrome.Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.Immunology and clinical manifestations of non-clonal mast cell activation syndromeAnaphylaxis as a clinical manifestation of clonal mast cell disorders.Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options.The transcriptome of the human mast cell leukemia cells HMC-1.2: an approach to identify specific changes in the gene expression profile in KitD816V systemic mastocytosis.The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells.Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA.Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing.Large scale DNA sequencing: new challenges emerge--the 2007 Human Genome Variation Society scientific meeting.
P2860
Q26748784-96FE3FF3-596F-4CA7-BA79-9F300319C33EQ26995624-22D5BFD8-679F-4D8F-9339-7B1E3D1FA816Q34024510-A0E150E3-4690-4B25-91A3-7795E1EF3741Q34564293-994F94C3-0A9A-44B3-AC0A-0E9E2B368DE0Q35010297-3DE3AB26-D2CD-431D-AD48-76289F8AA7A8Q36324486-B56FFC5A-C65C-4BFB-AC1C-EEC954D8593EQ36404141-6D193374-CFA4-47D2-95A6-EDA5950CFA21Q36568988-B571E4EF-F1CE-41A8-88C1-958A0682A438Q37276382-DA51F8E6-E4C5-4795-AE7E-65EA3D91D004Q37365376-E3969CAC-AB71-44BF-AC8A-948500E86346Q37854888-B2B8B0C7-2818-47B2-9EF6-ED049E8B6E07Q38041575-31E2FC9E-FB49-40D9-AC36-1D1EC4766B07Q38065108-36DF67AF-FDD6-4212-A4B8-E52468179619Q38221739-45F69794-98B4-45E7-A5AC-294BE31E9490Q38788064-08C26399-1279-45F7-8376-FA7FCA67CC5DQ39179443-D59DC345-FA13-4D66-B43F-0C38492F8BDEQ46394282-77F94CCD-5F8A-4341-9C1B-8D22B538005FQ47094811-775B2794-5885-4248-BAE9-D6E6BD5FD435Q47896520-FF71B956-B0E7-4A90-A1EB-3469509271E9Q51114888-BF99D142-C23C-49AE-A373-C6B6C04105CF
P2860
Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Multiple novel alterations in ...... mast cell activation disorder.
@en
type
label
Multiple novel alterations in ...... mast cell activation disorder.
@en
prefLabel
Multiple novel alterations in ...... mast cell activation disorder.
@en
P2093
P2860
P1476
Multiple novel alterations in ...... mast cell activation disorder.
@en
P2093
Christian Scheurlen
Gerhard J Molderings
Ivar Von Kügelgen
Jürgen Homann
Michael Brüss
Ulrich W Kolck
P2860
P304
P356
10.1080/00365520701245744
P577
2007-09-01T00:00:00Z